NNC0581-0001

N/A

Report date: 2024/11/25 11:39:09
NME

Base Information

Drug NameNNC0581-0001
Drug Alias NameNNC-0581-0001NN-6581
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionMitochondrial amidoxime-reducing component 1 inhibitors
TargetsMitochondrial amidoxime-reducing component 1
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseFatty Liver
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A

Develop Information

Active CompaniesNovo Nordisk A/S
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseFatty Liver
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A